Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
603669 Lionco Pharmaceutical Group
- 4.62
- +0.42+10.00%
Not Open Apr 24 15:00 CST
3.33BMarket Cap-25.52P/E (TTM)
4.62High4.22Low202.74KlotVolume4.26Open4.20Pre Close91.48MTurnover2.81%Turnover RatioLossP/E (Static)721.24MShares9.5452wk High4.70P/B3.33BFloat Cap3.4552wk Low4.62Limit Up721.24MShs Float20.05Historical High3.78Limit Down9.52%Amplitude2.94Historical Low--Dividend TTM4.51Avg Price115.36KlotAsk--Div YieldTTM100Lot Size78.77KlotBid
Lionco Pharmaceutical Group Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 92.95%379.78M | 53.34%231.03M | 25.29%141.48M | 4.85%76.86M | -31.95%196.83M | -40.02%150.67M | -43.62%112.92M | -41.82%73.3M | -60.93%289.26M | -61.59%251.21M |
| Operating revenue | 92.95%379.78M | 53.34%231.03M | 25.29%141.48M | 4.85%76.86M | -31.95%196.83M | -40.02%150.67M | -43.62%112.92M | -41.82%73.3M | -60.93%289.26M | -61.59%251.21M |
| Other operating revenue | 36.31%10.25M | ---- | -8.95%3.62M | ---- | 0.62%7.52M | ---- | 59.48%3.98M | ---- | 37.56%7.47M | ---- |
| Total operating cost | 31.83%466.36M | 5.47%269.78M | -4.06%173.78M | -0.25%94.76M | -22.66%353.77M | -20.82%255.79M | 11.78%181.13M | -8.72%94.99M | -35.25%457.43M | -45.91%323.06M |
| Operating cost | 92.19%201.74M | 65.99%131.55M | 35.35%77.72M | 19.81%33.01M | 12.73%104.97M | 35.10%79.25M | 69.39%57.42M | -1.59%27.55M | -39.01%93.12M | -48.67%58.66M |
| Operating tax surcharges | -4.98%4.82M | -29.73%2.2M | -39.35%1.44M | -53.11%660.14K | -19.51%5.07M | -39.79%3.14M | -45.88%2.37M | -31.48%1.41M | -34.41%6.3M | -39.03%5.21M |
| Operating expense | 18.00%142M | -15.57%75.16M | -34.11%44.25M | -13.72%38.12M | -49.14%120.34M | -51.62%89.03M | -16.80%67.15M | -20.82%44.18M | -44.18%236.62M | -52.76%184.01M |
| Administration expense | -4.54%89.52M | 3.50%64.91M | -4.23%38.9M | 1.41%18.53M | 3.15%93.78M | 9.79%62.72M | 26.65%40.62M | 14.64%18.28M | -0.19%90.91M | -8.28%57.13M |
| Financial expense | 233.87%1.62M | -4,519.82%-19.04M | 205.60%839K | -407.79%-332.16K | 141.97%483.97K | 122.29%430.72K | -17.62%274.54K | -75.48%107.92K | -118.01%-1.15M | -95.11%193.77K |
| -Interest expense (Financial expense) | 637.96%27.38M | 120.91%6.5M | -23.76%1.54M | -85.93%162.8K | -36.38%3.71M | -51.03%2.94M | -58.60%2.02M | -56.51%1.16M | -62.41%5.83M | -44.83%6.01M |
| -Interest Income (Financial expense) | 60.95%-1.29M | 59.70%-1.04M | 59.56%-722.45K | 52.87%-510.05K | 53.45%-3.31M | 56.01%-2.58M | 60.99%-1.79M | 51.71%-1.08M | 23.56%-7.11M | -11.30%-5.87M |
| Research and development | -8.45%26.66M | -29.39%14.99M | -20.01%10.64M | 37.51%4.77M | -7.91%29.12M | 18.86%21.23M | 24.85%13.3M | 88.67%3.47M | 38.86%31.63M | -4.28%17.86M |
| Credit Impairment Loss | -86.67%-18.77M | -87.38%-16.23M | -2,277.06%-14.87M | 178.59%805.41K | -44.93%-10.05M | -216.48%-8.66M | 83.40%-625.72K | -108.06%-1.02M | -179.52%-6.94M | -193.17%-2.74M |
| Asset Impairment Loss | -320.12%-32.3M | 97.67%-46.3K | 79.48%-43.09K | 80.06%-24.7K | 14.64%-7.69M | -485.14%-1.99M | 27.62%-210.04K | -16.92%-123.88K | -472.73%-9.01M | 78.38%-339.96K |
| Other net revenue | -630.35%-42.19M | -227.95%-14.24M | -3,293.46%-14.32M | 0.04%689.91K | 138.78%7.96M | 168.23%11.13M | -80.24%448.34K | -68.30%689.65K | -155.03%-20.51M | -88.10%4.15M |
| Fair value change income | 155.08%5.9M | 120.29%1.75M | -9.27%-3.18M | -28.21%-2.84M | -981.54%-10.72M | -490.71%-8.6M | -224.36%-2.91M | -201.51%-2.21M | 43.24%1.22M | -62.17%2.2M |
| Invest income | -233.36%-12.72M | -269.12%-11.99M | -270.65%-7.96M | -251.59%-3.42M | 59.11%-3.82M | -263.18%-3.25M | -238.60%-2.15M | 2,106.55%2.25M | -158.31%-9.33M | -72.81%1.99M |
| -Including: Investment income associates | -116.68%-15M | -154.02%-12.11M | -131.52%-8.03M | -296.52%-3.48M | 46.22%-6.92M | -315.99%-4.77M | -239.58%-3.47M | 323.43%1.77M | -895.93%-12.87M | 65.87%-1.15M |
| Asset deal income | -2,773.35%-2.24M | -2,706.14%-2.25M | -2,707.72%-2.25M | ---- | -81.28%83.63K | -81.69%86.34K | -81.69%86.34K | ---- | 4,551.88%446.66K | 4,798.78%471.43K |
| Other revenue | -55.35%17.92M | -56.71%14.52M | 123.65%13.99M | 242.90%6.17M | 1,194.18%40.15M | 1,208.31%33.54M | 218.27%6.26M | 250.26%1.8M | -87.33%3.1M | -89.43%2.56M |
| Operating profit | 13.57%-128.77M | 43.62%-53M | 31.20%-46.62M | 18.06%-17.21M | 21.04%-148.98M | -38.83%-93.99M | -267.29%-67.76M | -187.12%-21M | -365.26%-188.68M | -173.90%-67.71M |
| Add:Non operating Income | 621.37%1.55M | 2,494.60%5.57M | 2,494.57%5.57M | 20,798,512.69%1.1M | 7,536.76%214.81K | --214.81K | --214.81K | -99.36%5.28 | 16.99%2.81K | ---- |
| Less:Non operating expense | -76.71%509.84K | -86.35%278.91K | -88.67%143.62K | -60.68%75.23K | 1,541.55%2.19M | 1,922.90%2.04M | 1,331.48%1.27M | 536.73%191.35K | -79.51%133.34K | -72.01%100.97K |
| Total profit | 15.39%-127.73M | 50.22%-47.7M | 40.15%-41.19M | 23.62%-16.19M | 20.05%-150.95M | -41.32%-95.82M | -270.26%-68.82M | -188.02%-21.19M | -367.88%-188.81M | -174.30%-67.81M |
| Less:Income tax cost | 461.14%3.03M | -206.73%-812.92K | -187.43%-790.26K | -107.99%-143.76K | -92.34%540.84K | -54.32%761.66K | -80.06%903.92K | -48.79%1.8M | 54.18%7.06M | -86.52%1.67M |
| Net profit | 13.68%-130.76M | 51.45%-46.89M | 42.05%-40.4M | 30.23%-16.04M | 22.65%-151.5M | -39.02%-96.58M | -294.29%-69.72M | -211.83%-22.99M | -397.19%-195.86M | -188.07%-69.47M |
| Net profit from continuing operation | 13.68%-130.76M | 51.45%-46.89M | 42.05%-40.4M | 30.23%-16.04M | 22.65%-151.5M | -39.02%-96.58M | -294.29%-69.72M | -211.83%-22.99M | -397.19%-195.86M | -188.07%-69.47M |
| Net profit of parent company owners | 13.68%-130.76M | 51.45%-46.89M | 42.05%-40.4M | 30.23%-16.04M | 22.65%-151.5M | -39.02%-96.58M | -294.29%-69.72M | -211.83%-22.99M | -397.19%-195.86M | -188.07%-69.47M |
| Earning per share | ||||||||||
| Basic earning per share | 14.29%-0.18 | 46.15%-0.07 | 40.00%-0.06 | 33.33%-0.02 | 22.22%-0.21 | -30.00%-0.13 | -300.00%-0.1 | -200.00%-0.03 | -400.00%-0.27 | -190.91%-0.1 |
| Diluted earning per share | 14.29%-0.18 | 46.15%-0.07 | 40.00%-0.06 | 33.33%-0.02 | 22.22%-0.21 | -30.00%-0.13 | -300.00%-0.1 | -200.00%-0.03 | -400.00%-0.27 | -200.00%-0.1 |
| Other composite income | -2.27M | |||||||||
| Other composite income of parent company owners | ---2.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | 12.19%-133.03M | 51.45%-46.89M | 42.05%-40.4M | 30.23%-16.04M | 22.65%-151.5M | -39.02%-96.58M | -294.29%-69.72M | -211.83%-22.99M | -397.19%-195.86M | -188.07%-69.47M |
| Total composite income of parent company owners | 12.19%-133.03M | 51.45%-46.89M | 42.05%-40.4M | 30.23%-16.04M | 22.65%-151.5M | -39.02%-96.58M | -294.29%-69.72M | -211.83%-22.99M | -397.19%-195.86M | -188.07%-69.47M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.